![Michela Monego](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michela Monego
Comptroller/Controller/Auditor bei
21 Invest SGR SPA
Profil
Michela Monego is currently working as an Accounting Director at 21 Invest SGR SPA since 2001.
Prior to this, she worked as a Manager at Luxottica Group SpA and Bausch Health Cos., Inc.
Aktive Positionen von Michela Monego
| Unternehmen | Position | Beginn |
|---|---|---|
21 Invest SGR SPA
 21 Invest SGR SPA Investment ManagersFinance 21 Invest Italy invests in mid-market companies located in Italy. The firm focuses on the industrial manufacturing, food & beverage, healthcare and technology sectors. It provides financing for buyout transactions. [ [The Benetton Family reorganized its operating segments on September 4, 2026 by merging 21 Invest SGR SpA and Tages Capital SGR SpA forming 21 Next SpA. | Comptroller/Controller/Auditor | 01.01.2001 |
Ehemalige bekannte Positionen von Michela Monego
| Unternehmen | Position | Ende |
|---|---|---|
| LUXOTTICA GROUP | Corporate Officer/Principal | - |
| BAUSCH HEALTH COMPANIES INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Luxottica Group SpA
 Luxottica Group SpA Medical SpecialtiesHealth Technology Designs, manufactures and markets eye and sunglasses | Health Technology |
21 Invest SGR SPA
21 Invest SGR SPA Investment ManagersFinance 21 Invest Italy invests in mid-market companies located in Italy. The firm focuses on the industrial manufacturing, food & beverage, healthcare and technology sectors. It provides financing for buyout transactions. [ [The Benetton Family reorganized its operating segments on September 4, 2026 by merging 21 Invest SGR SpA and Tages Capital SGR SpA forming 21 Next SpA. | Finance |
Bausch Health Cos., Inc.
 Bausch Health Cos., Inc. Pharmaceuticals: OtherHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
